Frank Rimerman Advisors LLC boosted its holdings in shares of GE HealthCare Applied sciences Inc. (NASDAQ:GEHC – Free Report) by 7.2% throughout the third quarter, Holdings Channel experiences. The agency owned 3,225 shares of the corporate’s inventory after buying a further 216 shares throughout the quarter. Frank Rimerman Advisors LLC’s holdings in GE HealthCare Applied sciences had been price $303,000 on the finish of the latest quarter.
A lot of different hedge funds and different institutional buyers have additionally purchased and bought shares of GEHC. Capital Analysis World Traders grew its place in shares of GE HealthCare Applied sciences by 5.2% within the 1st quarter. Capital Analysis World Traders now owns 53,991,923 shares of the corporate’s inventory price $4,908,406,000 after shopping for a further 2,647,204 shares over the past quarter. Vanguard Group Inc. boosted its holdings in GE HealthCare Applied sciences by 9.2% within the first quarter. Vanguard Group Inc. now owns 48,519,340 shares of the corporate’s inventory valued at $4,410,893,000 after buying a further 4,107,746 shares within the final quarter. The Producers Life Insurance coverage Firm elevated its place in GE HealthCare Applied sciences by 18.0% throughout the 2nd quarter. The Producers Life Insurance coverage Firm now owns 1,245,961 shares of the corporate’s inventory valued at $97,088,000 after buying a further 189,956 shares throughout the interval. Sumitomo Mitsui Belief Holdings Inc. raised its holdings in GE HealthCare Applied sciences by 2.1% within the 1st quarter. Sumitomo Mitsui Belief Holdings Inc. now owns 1,025,320 shares of the corporate’s inventory price $93,212,000 after buying a further 20,776 shares within the final quarter. Lastly, Stonegate Funding Group LLC lifted its place in shares of GE HealthCare Applied sciences by 1.0% within the third quarter. Stonegate Funding Group LLC now owns 979,649 shares of the corporate’s inventory price $91,940,000 after buying a further 9,572 shares throughout the interval. Institutional buyers personal 82.06% of the corporate’s inventory.
Wall Avenue Analyst Weigh In
A lot of equities analysts not too long ago issued experiences on GEHC shares. BTIG Analysis raised shares of GE HealthCare Applied sciences from a “impartial” score to a “purchase” score and set a $100.00 value goal for the corporate in a analysis observe on Wednesday, September 18th. Evercore ISI raised their goal value on GE HealthCare Applied sciences from $98.00 to $102.00 and gave the corporate an “outperform” score in a analysis observe on Tuesday, October 1st. UBS Group reduce GE HealthCare Applied sciences from a “impartial” score to a “promote” score and lowered their value goal for the inventory from $84.00 to $74.00 in a analysis observe on Thursday, September twenty sixth. Redburn Atlantic raised GE HealthCare Applied sciences to a “strong-buy” score in a analysis report on Thursday, August 1st. Lastly, JPMorgan Chase & Co. began protection on shares of GE HealthCare Applied sciences in a analysis report on Monday, September ninth. They issued a “impartial” score and a $90.00 goal value on the inventory. One equities analysis analyst has rated the inventory with a promote score, 5 have assigned a maintain score, seven have assigned a purchase score and one has given a robust purchase score to the inventory. In response to MarketBeat, the corporate has a median score of “Reasonable Purchase” and a consensus goal value of $94.23.
View Our Newest Inventory Report on GEHC
GE HealthCare Applied sciences Buying and selling Down 2.8 %
NASDAQ:GEHC opened at $85.93 on Tuesday. The inventory has a market cap of $39.22 billion, a price-to-earnings ratio of 25.13, a PEG ratio of three.34 and a beta of 1.18. The corporate has a fast ratio of 0.82, a present ratio of 1.06 and a debt-to-equity ratio of 1.05. The corporate’s 50 day transferring common value is $88.43 and its 200-day transferring common value is $83.40. GE HealthCare Applied sciences Inc. has a 52 week low of $62.35 and a 52 week excessive of $94.55.
GE HealthCare Applied sciences (NASDAQ:GEHC – Get Free Report) final issued its earnings outcomes on Wednesday, July thirty first. The corporate reported $1.00 EPS for the quarter, beating the consensus estimate of $0.98 by $0.02. The enterprise had income of $4.84 billion for the quarter, in comparison with the consensus estimate of $4.88 billion. GE HealthCare Applied sciences had a return on fairness of 25.26% and a web margin of 8.10%. The corporate’s income was up .5% in comparison with the identical quarter final 12 months. Throughout the identical interval final 12 months, the enterprise posted $0.92 EPS. On common, equities analysis analysts forecast that GE HealthCare Applied sciences Inc. will publish 4.26 earnings per share for the present fiscal 12 months.
GE HealthCare Applied sciences Dividend Announcement
The enterprise additionally not too long ago introduced a quarterly dividend, which can be paid on Friday, November fifteenth. Shareholders of file on Friday, October 18th can be paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date is Friday, October 18th. GE HealthCare Applied sciences’s dividend payout ratio is at present 3.51%.
Insider Exercise
In associated information, CEO Thomas J. Westrick bought 2,750 shares of the inventory in a transaction that occurred on Wednesday, August seventh. The shares had been bought at a median value of $80.78, for a complete transaction of $222,145.00. Following the transaction, the chief government officer now owns 17,509 shares within the firm, valued at $1,414,377.02. This represents a 0.00 % lower of their possession of the inventory. The sale was disclosed in a doc filed with the Securities & Change Fee, which is out there at the SEC web site. Insiders personal 0.27% of the corporate’s inventory.
GE HealthCare Applied sciences Firm Profile
GE HealthCare Applied sciences Inc engages within the improvement, manufacture, and advertising of merchandise, providers, and complementary digital options used within the prognosis, therapy, and monitoring of sufferers in the USA, Canada, and internationally. The corporate operates via 4 segments: Imaging, Ultrasound, Affected person Care Options, and Pharmaceutical Diagnostics.
See Additionally
Wish to see what different hedge funds are holding GEHC? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for GE HealthCare Applied sciences Inc. (NASDAQ:GEHC – Free Report).
Obtain Information & Rankings for GE HealthCare Applied sciences Every day – Enter your electronic mail handle under to obtain a concise day by day abstract of the most recent information and analysts’ rankings for GE HealthCare Applied sciences and associated firms with MarketBeat.com’s FREE day by day electronic mail publication.
